{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:36:10Z","timestamp":1761744970443,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011635","name":"Chinese Academy of Medical Sciences & Peking Union Medical College Fuwai Hospital","doi-asserted-by":"publisher","award":["2023-GSP-GG-40","BJUHFCSOARF201801-06","NCRC2020013"],"award-info":[{"award-number":["2023-GSP-GG-40","BJUHFCSOARF201801-06","NCRC2020013"]}],"id":[{"id":"10.13039\/501100011635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["T-B-052"],"award-info":[{"award-number":["T-B-052"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.dsx.2023.102858","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T21:13:30Z","timestamp":1695244410000},"page":"102858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["One-year clinical outcomes of bivalirudin versus unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention"],"prefix":"10.1016","volume":"17","author":[{"given":"Yulong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changdong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhong","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuejin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runlin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinqing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8024-7024","authenticated-orcid":false,"given":"Xueyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2023.102858_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad192","article-title":"ESC Guidelines for the management of cardiovascular disease in patients with diabetes [J]","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.dsx.2023.102858_bib2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/1573403X15666191111123622","article-title":"Assessing cardiovascular risk in patients with diabetes: an update [J]","volume":"16","author":"Damaskos","year":"2020","journal-title":"Curr Cardiol Rev"},{"issue":"7","key":"10.1016\/j.dsx.2023.102858_bib3","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jcin.2011.04.008","volume":"4","author":"Witzenbichler","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"17","key":"10.1016\/j.dsx.2023.102858_bib4","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.jacc.2007.11.081","article-title":"Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial [J]","volume":"51","author":"Feit","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.dsx.2023.102858_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.thromres.2011.11.052","article-title":"Diabetes mellitus and thrombosis [J]","volume":"129","author":"Vazzana","year":"2012","journal-title":"Thromb Res"},{"issue":"33","key":"10.1016\/j.dsx.2023.102858_bib6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1556\/650.2018.31130","article-title":"[Diabetes mellitus: endothelial dysfunction and changes in hemostasis] [J]","volume":"159","author":"Babik","year":"2018","journal-title":"Orv Hetil"},{"issue":"4","key":"10.1016\/j.dsx.2023.102858_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1527-3466.2005.tb00177.x","article-title":"Bivalirudin: pharmacology and clinical applications [J]","volume":"23","author":"Shammas","year":"2005","journal-title":"Cardiovasc Drug Rev"},{"issue":"14","key":"10.1016\/j.dsx.2023.102858_bib8","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation [J]","volume":"42","author":"Collet","year":"2020","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.dsx.2023.102858_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1540-8183.2007.00262.x","article-title":"Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium [J]","volume":"20","author":"Gurm","year":"2007","journal-title":"J Intervent Cardiol"},{"key":"10.1016\/j.dsx.2023.102858_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221113344","article-title":"Impact of diabetes mellitus on one-year clinical outcomes in patients anticoagulated with bivalirudin undergoing elective percutaneous coronary intervention [J]","volume":"28","author":"Li","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"issue":"9","key":"10.1016\/j.dsx.2023.102858_bib11","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.amjcard.2009.06.035","article-title":"Comparison of bivalirudin monotherapy versus unfractionated heparin plus tirofiban in patients with diabetes mellitus undergoing elective percutaneous coronary intervention [J]","volume":"104","author":"Tavano","year":"2009","journal-title":"Am J Cardiol"},{"issue":"10366","key":"10.1016\/j.dsx.2023.102858_bib12","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(22)01999-7","article-title":"Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial [J]","volume":"400","author":"Li","year":"2022","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.dsx.2023.102858_bib13","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1001\/jama.2015.2323","article-title":"Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial [J]","volume":"313","author":"Han","year":"2015","journal-title":"JAMA"},{"issue":"Suppl_1","key":"10.1016\/j.dsx.2023.102858_bib14","article-title":"One-year safety and effectiveness of bivalirudin in patients undergoing elective percutaneous coronary intervention [J]","volume":"144","author":"Li","year":"2021","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.dsx.2023.102858_bib15","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction [J]","volume":"60","author":"Thygesen","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.dsx.2023.102858_bib16","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions [J]","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.dsx.2023.102858_bib17","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium [J]","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.dsx.2023.102858_bib18","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jacc.2005.02.074","article-title":"Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial [J]","volume":"45","author":"Gurm","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.dsx.2023.102858_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40256-015-0113-8","article-title":"Bivalirudin versus heparin plus glycoprotein IIb\/IIIa inhibitors in patients with diabetes mellitus undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials [J]","volume":"15","author":"Ibebuogu","year":"2015","journal-title":"Am J Cardiovasc Drugs"},{"issue":"4","key":"10.1016\/j.dsx.2023.102858_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2147\/vhrm.2006.2.4.357","article-title":"Bivalirudin in percutaneous coronary intervention [J]","volume":"2","author":"Lehman","year":"2006","journal-title":"Vasc Health Risk Manag"},{"issue":"1","key":"10.1016\/j.dsx.2023.102858_bib21","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1038\/s41598-023-34008-y","article-title":"Prolonged infusion of bivalirudin after elective percutaneous coronary intervention protects against procedural myocardial injury (a COBER study)-a randomized trial [J]","volume":"13","author":"Wu","year":"2023","journal-title":"Sci Rep"},{"issue":"36","key":"10.1016\/j.dsx.2023.102858_bib22","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1093\/eurheartj\/ehu214","volume":"35","author":"Zeymer","year":"2014","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.dsx.2023.102858_bib23","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction [J]","volume":"358","author":"Stone","year":"2008","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.dsx.2023.102858_bib24","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1311096","article-title":"Bivalirudin started during emergency transport for primary PCI [J]","volume":"369","author":"Steg","year":"2013","journal-title":"N Engl J Med"},{"issue":"9696","key":"10.1016\/j.dsx.2023.102858_bib25","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(09)61484-7","article-title":"Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial [J]","volume":"374","author":"Mehran","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2023.102858_bib26","article-title":"Safety and efficacy of bivalirudin versus unfractionated heparin monotherapy in patients with CAD and DM undergoing PCI: a retrospective observational study","volume":"2022","author":"Li","year":"2022","journal-title":"[J]. Cardiovasc Ther"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402123001546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402123001546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:24:52Z","timestamp":1761729892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402123001546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1871402123001546"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2023.102858","relation":{},"ISSN":["1871-4021"],"issn-type":[{"type":"print","value":"1871-4021"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-year clinical outcomes of bivalirudin versus unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2023.102858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC).","name":"copyright","label":"Copyright"}],"article-number":"102858"}}